Blum Robert I

About Blum Robert I

Robert I. Blum is the President and Chief Executive Officer of Cytokinetics, Inc. and a member of the company’s Board of Directors. According to the company’s published biography, he has served in those roles since 2007. Prior to that, he had served as Cytokinetics’ President and, since participating in the launch of the company’s operations in 1998, held senior positions spanning research and development, finance, corporate development, legal affairs, commercial operations, and business development. Before joining Cytokinetics, Blum held senior business development and marketing roles at COR Therapeutics from 1991 to 1998. His earlier career also included positions of increasing responsibility in sales, marketing, and other pharmaceutical business functions at Marion Laboratories and Syntex Corporation beginning in 1981. That background gave him broad experience across commercialization, corporate strategy, and operational execution in the life sciences sector. At Cytokinetics, he has been a central figure in the company’s long-term evolution into a publicly traded biopharmaceutical company focused on muscle biology and therapies for diseases associated with muscle dysfunction and weakness. The company’s materials show him guiding strategy through major corporate and clinical milestones, including multi-year development plans, pipeline updates, and broader organizational transformation. He is also frequently quoted in company communications on regulatory, clinical, commercial, and governance topics, reflecting his hands-on leadership style and long tenure. Blum’s experience extends beyond executive management. He previously served on the faculty at the Center for BioEntrepreneurship at the University of California, San Francisco, where he taught a corporate finance course to graduate students. He has also been involved in scientific and philanthropic initiatives, including service connected to the Weizmann Institute of Science. Overall, his profile reflects a seasoned biopharmaceutical executive with deep experience in company building, product-development strategy, and cross-functional leadership.